IMMUNOME INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 44,389 | $298,738 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 23, 2025 |
| June 30, 2025 | 44,389 | $412,818 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 14, 2025 |
| Sept. 30, 2025 | 44,389 | $519,795 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 13, 2025 |
| Dec. 31, 2025 | 44,389 | $953,476 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Jan. 15, 2026 |
| March 31, 2026 | 44,389 | $970,787 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 13, 2026 |
| June 30, 2026 | 44,389 | $940,603 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 13, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.